Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guimu Guo

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 13, 2025
Signal mining for non-bleeding adverse event in novel oral anticoagulants: a pharmacovigilance study based on FAERS databaseGuimu Guo, Ying Song, Sijie Chang, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 12, 2021
Biological Network MiningZongliang Yue, Da Yan, Guimu Guo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 5, 2025
Physiologically-based pharmacokinetic modeling to predict the exposure and to assess pharmacodynamics of daptomycin in infants within 1 year oldLingling Ye, Hong Zhou, Guimu Guo, et al.
Scientific Reports|November 18, 2025
A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting systemLingling Ye, Guimu Guo, Hong Zhou, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|June 11, 2019
Scalable De Novo Genome Assembly Using a Pregel-Like Graph-Parallel SystemGuimu Guo, Hongzhi Chen, Da Yan, et al.
Cardiovascular Toxicology|October 17, 2025
Argatroban-Associated Adverse Events: An Analysis Based on FDA Adverse Event Reporting System (FAERS)Changyu Ren, Guimu Guo, YiXuan Wang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 11, 2025
Venous thromboembolism events associated with tofacitinib in rheumatoid arthritis patients: a real-world study from FAERS databaseJintuo Zhou, Ruihong Cai, Peiguang Niu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 9, 2025
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of tacrolimus in pregnant women with infection diseaseJianwen Xu, Guimu Guo, Shuifang Zhou, et al.
Clinical Pharmacology and Therapeutics|December 10, 2022
Physiologically-Based Pharmacokinetic Modeling of Omalizumab to Predict the Pharmacokinetics and Pharmacodynamics in Pediatric PatientsGuimu Guo, Xiang You, Wanhong Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 2022
Application of PBPK modeling in predicting maternal and fetal pharmacokinetics of levetiracetam during pregnancyJiarui Chen, Xiang You, Wanhong Wu, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 13, 2025
Signal mining for non-bleeding adverse event in novel oral anticoagulants: a pharmacovigilance study based on FAERS databaseGuimu Guo, Ying Song, Sijie Chang, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 12, 2021
Biological Network MiningZongliang Yue, Da Yan, Guimu Guo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 5, 2025
Physiologically-based pharmacokinetic modeling to predict the exposure and to assess pharmacodynamics of daptomycin in infants within 1 year oldLingling Ye, Hong Zhou, Guimu Guo, et al.
Scientific Reports|November 18, 2025
A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting systemLingling Ye, Guimu Guo, Hong Zhou, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|June 11, 2019
Scalable De Novo Genome Assembly Using a Pregel-Like Graph-Parallel SystemGuimu Guo, Hongzhi Chen, Da Yan, et al.
Cardiovascular Toxicology|October 17, 2025
Argatroban-Associated Adverse Events: An Analysis Based on FDA Adverse Event Reporting System (FAERS)Changyu Ren, Guimu Guo, YiXuan Wang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 11, 2025
Venous thromboembolism events associated with tofacitinib in rheumatoid arthritis patients: a real-world study from FAERS databaseJintuo Zhou, Ruihong Cai, Peiguang Niu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 9, 2025
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of tacrolimus in pregnant women with infection diseaseJianwen Xu, Guimu Guo, Shuifang Zhou, et al.
Clinical Pharmacology and Therapeutics|December 10, 2022
Physiologically-Based Pharmacokinetic Modeling of Omalizumab to Predict the Pharmacokinetics and Pharmacodynamics in Pediatric PatientsGuimu Guo, Xiang You, Wanhong Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 2022
Application of PBPK modeling in predicting maternal and fetal pharmacokinetics of levetiracetam during pregnancyJiarui Chen, Xiang You, Wanhong Wu, et al.
Pageof 2